|
|
|
| United States Patent | 5366448 |
| Link to this page | http://www.wikipatents.com/5366448.html |
| Inventor(s) | Basilice; Vincent P. (2500-50 Nesconset Hwy., Bldg. 14, Stony Brook, NY 11790);
Basilice; Joseph P. (10 Landview Dr., Dix Hills, NY 11746) |
| Abstract | An eye drop dispensing device (10), designed to replace the cap (18) of an
eye drop squeeze bottle (12) includes a positioning member (38). The
positioning member is brought to bear against a boundary (54) of a
patient's (14) lower eyelid (36), and the assembly (52) rotated about the
member to bring a nozzle tip (24) of the device in facing relation with
the eye (32). Besides providing stability to the assembly, the member
assists in the eversion of the lower eyelid to form a well-like
configuration (61) to receive drops (28). Thus, the patient may maintain a
primary gaze position (17), facilitating the eye drop dispensing
procedure. |
|
|
|
Title Information  |
|
|
|
|
|
Drawing from US Patent 5366448 |
|
|
Dispensing eye drops |
|
|
|
|
|
| Publication Date |
November 22, 1994 |
|
|
|
|
|
| Filing Date |
June 28, 1993 |
|
|
|
|
|
|
|
|
|
|
|
| Parent Case |
This application is a continuation of PCT/US93/03619 filed Apr. 19, 1993,
which international application is a continuation-in-part of U.S. Ser. No.
07/871,100, filed Apr. 20, 1992, now abandoned. |
|
|
|
|
|
|
|
|
|
|
|
|
|
Title Information  |
|
|
Description  |
|
|
BACKGROUND OF THE INVENTION
The present invention relates generally to improvements for facilitating
the dispensing of eye drops, the improvements more particularly obviating
such prior art shortcomings as requiring a tilted-back head position,
preventing inadvertent blinking and other occurrences during
administration of the eye drops which are counterproductive to achieving
the purposes intended.
It is already part of prior art practice employing commercially available
squeeze bottle or equivalent eye drop dispensers to use positioning
devices to direct the dispensed eye drops onto the eye surface where
needed. Such positioning devices are exemplified by the tripod support of
Campagna, et al. of U.S. Pat. No. 3,934,590, issue on Jan. 27, 1976, and
the eye-encircling dispenser support of Bechtle of U.S. Pat. No.
4,531,944, issued on Jul. 30, 1985. These, and all other known prior art
combined supports and dispensers, while beneficial, still have
shortcomings. Such shortcomings include requiring special head positions
and other special procedures or techniques that, at best, make
self-application difficult and, more often, prevent the user from
achieving proper eye treatment using eye drops. The prior art dispensers
can sometimes even contribute to the spreading of the eye infection with
an inadvertently contaminated dispenser.
The present invention is intended to provide a safe and effective eye drop
dispensing method and components for its practice, overcoming the
foregoing and other shortcomings of the prior art. Using the present
invention, eye drops are more efficiently administered, reducing waste.
This is of particular importance with certain medicinal eye drops, which
are particularly expensive. Further, the present invention dispenses eye
drops with the recipient's or patient's head in a natural position and
otherwise with such ease that self-application is possible. As such, the
present invention may be used even by the elderly and by patients with
poor eyesight, crippling arthritis or other heretofore interfering
handicaps.
SUMMARY OF THE INVENTION
An improved eye drop assembly includes an inventive dispensing device
secured to an eye drop dispenser. An improved method of administering
drops of fluid medication allows a patient to maintain their head in an
erect orientation.
The eye drop dispensing device includes a cylindrical, dome-shaped collar.
The collar has an opening extending along a collar axis adapted to receive
a dispenser nozzle of the dispenser and internal threads adapted to engage
corresponding external threads on the dispenser.
A positioning member is attached to and extends away from the collar. The
positioning member assists in an eversion of a lower eyelid of a patient
to form a bowed configuration suitable to receive drops. Further, the
positioning member is sized to act as a point upon which the assembly may
pivot such that in an operative orientation, drops from the dispenser may
be received by the bowed configuration of the lower eye lid. This greatly
reduces fluid medication waste while simultaneously increasing the ease
with which patients may deliver their own drops.
BRIEF DESCRIPTION OF THE DRAWING
The description of the invention which follows, together with the
accompanying drawings should not be construed as limiting the invention to
the example shown and described, because those skilled in the art to which
this invention appertains will be able to devise other forms thereof
within the ambit of the appended claims:
FIG. 1 is a side elevational view of a known, commonly-called squeeze
bottle eye drop dispenser in assembled relation to an inventive eye drop
dispensing device member in an operative position preparatory to use
according to the present invention;
FIG. 2 is a partial front view of a patient's face that best illustrates
the FIG. 1 operative position or location of the present dispensing device
when in use;
FIG. 3 is a prior art figure showing in an isolated cross-section a popular
squeeze bottle eye drop dispenser in current use that may be utilized for
use in accordance with the inventive eye drop dispensing apparatus and
method;
FIG. 4, is a plan elevational view of the inventive eye drop dispensing
device prior to the squeeze bottle being assembled thereto;
FIG. 5 is a side view of the inventive eye drop dispensing device prior to
the squeeze bottle being assembled thereto;
FIG. 6 is a front elevational view of the inventive eye drop dispensing
device prior to the squeeze bottle being assembled thereto;
FIG. 7 is a partial detail view as taken along line 7--7 of FIG. 5;
FIG. 8 is a partial detail view as taken along line 8--8 of FIG. 7;
FIG. 9 is a side elevational view of the eye drop dispensing device of
FIGS. 4, 5 and 6 in assembled relation with the squeeze bottle eye drop
dispenser of FIG. 3; and
FIG. 10 is a view similar to FIG. 1, but shown in cross section as taken
along line 10--10 of FIG. 2, and further showing respectively in phantom
and full line perspective the positions of movement of the assembled eye
drop dispenser of FIG. 9.
DETAILED DESCRIPTION OF A PREFERRED EMBODIMENT
An assemblage 52 of a preferred embodiment of an eye drop dispensing device
10 is illustrated in FIGS. 1 and 9. Diespensing device 10 is assembled to
a standard eye drop dispenser squeeze bottle 12 and in a first operative
position 54 preparatory to use by a patient 14. That is, and understood to
be used almost exclusively, is a popular present day eye drop dispenser
16, herein shown in the prior after FIG. 3, which consists of a pliable or
squeezable plastic bottle 12 with removable cap member 18. Cap 18 has
internal threads 20 of an appropriate selected pitch to engage external
threads 22 on bottle 12. Cap 18 is sized to seal the outlet opening 24 of
the bottle dispenser nozzle 26 when threads 20, 22 are threadably engaged.
Bottle 12 in practice is usually commercially sold in a 1/2 fluid ounce
size, and is of flexible plastic and, of course, of any convenient shape
appropriate to store fluid medication 28.
In the prior art, when using bottle 12 to apply medication 28 to a surface
30, i.e. the cornea/sclera, of an eyeball 32, the patient 14 was required
to tilt his/her head 15 "all the way back" or even to assume the supine
position. Bottle 12, with cap 18 removed is then inverted and from an
above clearance position above the target eye 32, the patient 14 attempts
to "squeeze off" a single drop of medication 28. As often inadvertently
happens, however, the drop misses the eye surface 30 completely, or the
patient yields to a reflex action and blinks covering the eye surface 30
and consequently wasting the medication 28. In attempting to position
bottle 12 properly above eye 32, another prior art shortcoming may result
from the patient touching the infected surface 30 or eyelids 34, 36 and
causing contamination of the dispensing outlet which can result in
reinfection of eye 32 as subsequent doses are applied.
The dispensing device 10, as shown in FIGS. 4, 5, 6 and 7, is comprised in
part of a positioning member 38 whose outer or unattached end 40 is
provided with a somewhat triangular, contoured pad 42 having a
suction-like cup design, as best seen in FIGS. 5, 7 and 8, to facilitate
the engagement of end 40 with the patient's lower eyelid 36. (See FIGS. 1
and 9). At its opposite or inner end 44, member 38 is joined to a
cylindrical dome-shaped collar 46. Collar 46 is constructed with internal
threads 20 of a selected pitch to readily engage external threads 22 on
bottle 12 after cap 18 has been removed. Collar 46 also includes an
opening 47 extending along a collar axis 48, the opening 47 adapted to
receive dispenser nozzle 26 of bottle dispenser 12. In a preferred
embodiment, device 10 is made from a flexible material such as rubber.
After cap 18 has been replaced by device 10 on bottle 12 providing the
assembly 52 of FIG. 9, the assembly 52 is advantageously gripped and held
between the thumb 53 and forefinger 55 of one hand and moved into the
operative position of FIG. 1. The assembly 52, and especially pad 42 is
brought to bear against the patient's eye lower boundary 54 of lower lid
36 at the tarsal palpebral area, as best shown in FIGS. 1 and 10. It is
contemplated that assembly 52 will be moved with a combined motion inward
along arrow 56 and downward along arrow 58 in conjunction with a careful
rotation along a path 60 about member 38, to bring nozzle tip 24 of nozzle
26 to a clearance position 62 in facing relation to eye 32 of patient 14.
Thus, member 38 provides stability to assembly 52. Nozzle 26 and nozzle
tip 24 are used to dispense fluid medication 28. Clearance position 62 is
defined approximately in FIG. 10 by the phantom perspective outline of
assembly 52. A preferred clearance position 62 places tip 24 within 10 mm
of corneal surface 30, adjacent eye 32 and most significantly above the
now bowed or distended tarsal plate 59 of lower lid 36, which the
movements 56 and 58 have effectively caused to undergo an eversion of
approximately 3 to 4 mm to form an extended well-like or trough
configuration 61. In a preferred embodiment only positioning member 38
extends away from dome shaped collar 46 to limit possible interference
with the use of dispensing device 10.
To obtain the preferred clearance position 62 and desired eversion 61, it
is preferred that positioning member 38 be angularly offset from collar
axis 48 by an angle 50. The offset angle 50 is preferably between 10 and
80 degrees and most preferably approximately 30 degrees, as best shown in
FIG. 5. Further, an upper outer surface 70 of positioning member 38
preferably has a dimension 71 extending approximately 19 mm away from
collar 46, while a component of length 72 for lower outer surface 73,
extending along collar axis 48, is approximately 28 mm. The distance
between surfaces 70 and 73 is preferably approximately 7 mm. Finally, the
axial displacement 74, measured along collar axis 48, between tip 24 and
an edge 76 of pad 42 adjacent to tip 24, as shown in FIG. 9, is less than
10 mm, preferably within a range of between 3 and 5 mm, and most
preferably at 4.5 mm.
Once tip 24 is placed in position 62, axis 48 of collar 46, and axis 64 of
bottle 12 are now virtually parallel and possibly coincident with a
primary gaze axis 17. (See FIG. 10). Preferably, assembly 52 is pivoted
between 30 and 60 degrees beyond gaze axis 17, as shown in phantom in FIG.
10, so that tip 24 has an axial displacement within 1 mm of edge 76 as
measured along gaze axis 17. Thus, the force of gravity may be used to
promote the depositing of fluid medication 28 within the bowed
configuration 61. Further, this operative orientation is preferred since,
at the time of the administration of the eye drops, the patient's head is
in an erect orientation most advantageous for this procedure, and is a
head position to be distinguished from the prior art practice in which the
patient's head is tilted back and the eye drops dispensed from an above
clearance position directly onto the patient's eyeball or cornea/sclera
surface 30.
The use of primary gaze axis 17 promotes the depositing of drops of fluid
medication 28 behind the patient's lower eyelid 36, which has effectively
previously undergone eversion to present bowed configuration 61 suitable
for receiving drops of fluid medication 28 from outlet opening 24.
Obviated is the prior art shortcoming in which the eye drop is
administered off-target, or the patient yields to the reflex action of
blinking and thus blocking the eye drop from making contact with the eye
surface. This reduces waste, which is of particular importance when using
certain very expensive medicinal fluid medications 28. The patient 14 is
not required to assume an ungainly head position and is much less likely
to blink as in the prior art. By virtue of the ease of eye drop
administration or application in accordance with the present invention,
even elderly patients or patients with poor eyesight or crippling
arthritis can now deliver their own eye drops, not relying on others for
assistance, which will promote patient confidence and compliance.
As illustrated in FIG. 2, a prepositioning of the index finger 66 of the
patient's free hand is recommended to help accomplish the bowing of lower
lid 36. With assembly 52 held in this relation to bowed lid 36, medication
28 is now ready to be dispensed within the extended well-like or trough
configuration 61 of lid 36, one drop at a time.
In an alternative embodiment, it is envisioned that bottle 12 may include a
portion of the structure of dispensing device 10. For example, positioning
arm 38 may be integral to the bottle 12.
For completeness sake it is noted that, after the drop delivery is
completed, the patient 14 preferably removes the assembly 52 and relocates
pad 42 at the inferior punctum 68, which is at the juncture of nose 69 and
lower lid 36, as best shown in FIG. 2. By maintaining slight pressure for
about one minute at the inferior punctum 68, as is well understood, slows
the runoff of medication 28 by occluding the common canicululor canal.
Preferred embodiments of the present invention have been described. It is
to be understood that variations and modifications may be employed without
departing from the scope of the present invention. Accordingly, the
following claims should be studied to determine the true scope of the
present invention.
* * * * *
|
|
|
|
|
Description  |
|